furosemide has been researched along with idazoxan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Antonio De Luca, L; Oliveira Margatho, L; Pereira Barbosa, S; Vanderlei Menani, J | 1 |
| Andrade, CA; Barbosa, SP; De Luca, LA; Menani, JV | 1 |
| Barbosa, SP; Colombari, DS; de Luca, LA; de Paula, PM; Gasparini, S; Menani, JV | 1 |
7 other study(ies) available for furosemide and idazoxan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake.
Topics: Amphetamines; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebellar Nuclei; Clonidine; Diuretics; Drinking; Drinking Behavior; Furosemide; Idazoxan; Imidazoline Receptors; Injections, Intraventricular; Male; Methysergide; Rats; Rats, Sprague-Dawley; Receptors, Drug; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride, Dietary | 2002 |
Activation of alpha2-adrenergic receptors into the lateral parabrachial nucleus enhances NaCl intake in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Appetite; Blood Pressure; Captopril; Diuretics; Drinking Behavior; Furosemide; Genes, fos; Idazoxan; Imidazoles; Immunohistochemistry; Male; Pons; Prosencephalon; Rats; Receptors, Adrenergic, alpha-2; Sodium Chloride, Dietary | 2004 |
Adrenergic mechanisms of the Kölliker-Fuse/A7 area on the control of water and sodium intake.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Captopril; Dietary Sucrose; Drinking Behavior; Furosemide; Idazoxan; Male; Natriuretic Agents; Norepinephrine; Pons; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Water | 2009 |